$15.94
$0.00 (0.00%)
End-of-day quote: 05/10/2024
NasdaqCM:CPRX
Add to Portfolio

Catalyst Pharmaceuticals Annual Report

Year Year 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
Rev. Revenue
$398.20M $214.20M $140.83M $119.07M $102.31M $0.50M $0.00M $0.00M $0.00M $0.00M $0.00M $0.00M $0.00M $0.49M $0.00M $0.00M $0.00M $0.00M
GM % Gross Margin %
63.56% 74.71% 72.44% 71.84% 67.16% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 100.00% 0.00% 0.00% 0.00% 0.00%
OM Operating Margin
21.80% 47.54% 37.20% 34.69% 31.11% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Earnings Per Share
$0.00 $0.63 $0.75 $0.37 $0.40 $0.30 $-0.33 $-0.21 $-0.22 $-0.25 $-0.23 $-0.23 $-0.17 $-0.29 $-0.22 $-0.48 $-0.81 $-0.33 $-0.36
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sha. Shares
107.12m 105.26m 102.99m 103.78m 103.4m 102.74m 102.55m 82.97m 82.85m 69.12m 54.13m 41.42m 24.7m 19.39m 18.04m 14.06m 12.53m 12.52m
OCF Operating Cash Flow
$143.60M $116.05M $60.37M $45.03M $34.61M $-26.15M $-13.74M $-17.96M $-18.02M $-12.94M $-9.88M $-5.14M $-4.99M $-3.76M $-7.68M $-8.26M $-4.42M $-1.18M
FCF Free Cash Flow
$116.05M $116.02M $59.35M $45.02M $34.59M $-30.64M $-16.60M $-18.06M $-18.04M $-13.00M $-9.89M $-5.19M $0.00M $0.00M $0.00M $0.00M $-4.49M $-1.20M
FCFS Free Cash Flow Per Share
$-1.28 $1.03 $0.57 $0.43 $0.34 $-0.26 $-0.16 $-0.22 $-0.22 $-0.20 $-0.22 $-0.17 $-0.23 $-0.20 $-0.51 $-0.63 $-0.36 $-0.16